Skip to main content

Anaesthetic implications of drug abuse in trauma patients

  • Chapter
Trauma Operative Procedures

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

  • 123 Accesses

Abstract

It is increasingly recognised that drug abuse not only contributes to the trauma patient population but also that the effects of acute and chronic drug toxicity have major implications for patient management. The role of drug abuse as a factor associated with morbidity and mortality in the trauma setting has not been properly quantified. Physicians dealing with victims of acute trauma will however, inevitably have to deal with the associated problems of drug abuse. For optimal management of these patients a thorough working knowledge of commonly abused drugs is required.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Government Statistical Service (1997) Statistical bulletin. Department of Health, p 1.

    Google Scholar 

  2. Kirby JM, Maull KI, Fain W (1992) Comparability of alcohol and drug use in injured drivers. Southern Med Journal 85:800–801.

    Article  CAS  Google Scholar 

  3. Lindenbaum GA, Carrol SF, Daskal I et al (1989) Patterns of alcohol and drug abuse in an urban trauma center: the increasing role of cocaine abuse. J Trauma 29:1654–1658.

    Article  PubMed  CAS  Google Scholar 

  4. Soderstrom CA, Dischinger PC, Smith GS et al (1992) Psychoactive substance dependence among trauma center patients. JAMA 267:2756–2759

    Article  PubMed  CAS  Google Scholar 

  5. Department of Transport (1997) News release, press notice 149/Transport.

    Google Scholar 

  6. Galbraith S (1976) Misdiagnosis and delayed diagnosis of traumatic intracranial haematoma. British Medical Journal 1:1438.

    Article  PubMed  CAS  Google Scholar 

  7. Abelson HI, Miller JD (1985) A decade in trends in cocaine use in the household population. Nat Inst Drug Abuse Res Monogr Ser 61:35–49.

    CAS  Google Scholar 

  8. Marzuk PM, Tardiff K, Leon AC et al (1995) Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Eng J Med 26:1753.

    Article  Google Scholar 

  9. Pasternack PF, Colvin SE, Baumann FG (1985) Cocaine induced angina pectoris and myocardial infarction in patients younger than 40 years. Am J Cardiol 55:847.

    Article  PubMed  CAS  Google Scholar 

  10. Isner JM, Estes M, Thompson PD et al (1986) Acute cardiac events temporarily related to cocaine abuse. N Engl J Med 315:1438.

    Article  PubMed  CAS  Google Scholar 

  11. Barth CW, Bray M, Roberts WC (1986) Rupture of the ascending aorta during cocaine intoxication. Am J Cardiol 57:496.

    Article  PubMed  Google Scholar 

  12. Chokshi SK, Moore R, Pondion NG et al (1989) Reversible cardiomyopathy associated with cocaine intoxication. Ann Intern Med 111:1039.

    PubMed  CAS  Google Scholar 

  13. Lange RA, Cigarroa RG, Yancy CW Jr et al (1989) Cocaine induced coronary artery vasoconstriction. N Eng J Med 321:1557–1562.

    Article  CAS  Google Scholar 

  14. Cregler LL, Mark H (1986) Cardiovascular dangers of cocaine abuse. Am J Cardiol 57:1185.

    Article  PubMed  CAS  Google Scholar 

  15. Lange RA, Cigarroa RG, Flores ED et al (1990) Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 112:897–903.

    PubMed  CAS  Google Scholar 

  16. Ramoska E, Sacchetti AD (1985) Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med 14:1112.

    Article  PubMed  CAS  Google Scholar 

  17. Gay GR, Loper KA (1988) The use of labetolol in the management of cocaine crisis. Ann Emerg Med 17:282–283.

    Article  PubMed  CAS  Google Scholar 

  18. Dusenberry SJ, Hicks MJ, Mariani PJ (1987) Labetalol treatment of cocaine toxicity. Ann Emerg Med 16:235.

    Article  PubMed  CAS  Google Scholar 

  19. Pollan S, Tadjziechy M (1989) Esmolol in the management of epinephrine and cocaine induced cardiovascular toxicity. Anesth Analg 69:663–664.

    Article  PubMed  CAS  Google Scholar 

  20. Derlet RW, Albertson TE (1990) Potentiation of cocaine toxicity with lidocaine. Ann Emerg Med 19:464.

    Google Scholar 

  21. Itkonen J, Schnoll S, Glassroth J (1984) Pulmonary dysfunction in “freebase” cocaine users. Arch Int Med 144:2195.

    Article  CAS  Google Scholar 

  22. Shesser R, Davis C, Edelsten S (1981) Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine. Ann Emerg Med 10:213.

    Article  PubMed  CAS  Google Scholar 

  23. Patal RC, Dutta D, Schonfeld SA (1987) Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Intern Med 107:186.

    Google Scholar 

  24. Campbell D, Parr MJA, Shutt LE (1996) Unrecognised crack cocaine abuse in pregnancy. Br J Anaesthesia 77:553–555.

    Article  CAS  Google Scholar 

  25. Derlet RW, Albertson TE (1986) Emergency department presentation of cocaine intoxication. Ann Emerg Med 18:182.

    Article  Google Scholar 

  26. Seaman ME (1990) Acute cocaine abuse associated with cerebral infarction. Ann Emerg Med 19:34.

    Article  PubMed  CAS  Google Scholar 

  27. Lichtenfeld PJ, Rubin DB, Feldman RS (1984) Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol 411:223.

    Article  Google Scholar 

  28. Peterson PL, Roszler M, Jacobs I et al (1991) Neurovascular complications of cocaine abuse. J Neuropsychiat Clin Neurosci 3:143.

    CAS  Google Scholar 

  29. Kay BR, Fainstate M (1987) Cerebral vasculitis associated with cocaine abuse. JAMA 258:2104.

    Article  Google Scholar 

  30. Myers JA, Barnett MF (1984) Generalized seizures and cocaine abuse. Neurology 344:1675.

    Google Scholar 

  31. Merigian KS, Roberts JR (1987) Cocaine intoxication: hyperyrexia, rhabdomyolysis, and acute renal failure. Clin Toxicol 25:135.

    Article  CAS  Google Scholar 

  32. Perinol LE, Warren GE, Levine JS (1987) Cocaine induced hepatoxicity in humans. Gastroenterology 93:176.

    Google Scholar 

  33. Stoelting RK, Creassor CW, Martz RC (1975) Effects of cocaine on halothane MAC in dogs. Anesth Analg 54:422.

    PubMed  CAS  Google Scholar 

  34. Matera C, Warren WB, Moomjy M et al (1990) Prevalence of the use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 163:797.

    PubMed  CAS  Google Scholar 

  35. Woods JR, Plessinger MA, Clark KE (1987) Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257:957.

    Article  PubMed  CAS  Google Scholar 

  36. Derlet RW, Albertson TE (1989) Agents that protect against cocaine induced death and seizures. Ann Emerg Med 18:446.

    Article  Google Scholar 

  37. Goetting MG (1985) Neurotoxicity of meperidine. Ann Emerg Med 14:1007.

    Article  PubMed  CAS  Google Scholar 

  38. Stone PA, MacIntyre PE, Jarvis DA (1993) Norpethidine toxicity and patient controlled analgesia. BJA 71:738–740.

    Article  PubMed  CAS  Google Scholar 

  39. Duberstein JL, Kaufman DM (1971) A clinical study of an epidemic of heroin intoxication and heroin induced pulmonary oedema. Am J Med 51:704

    Article  PubMed  CAS  Google Scholar 

  40. National Safety Council (1996) Accident facts. National Safety Council, Itasca.

    Google Scholar 

  41. Goldfrank LR (1984) The several uses of naloxone. Emerg Med 16:105.

    Google Scholar 

  42. Tandberg D, Abercrombie D (1982) Treatment of heroin overdosage with endotracheal naloxone. Ann Emerg Med 11:443.

    Article  PubMed  CAS  Google Scholar 

  43. George CF, Robertson D (1987) Clinical consequences of abrupt drug withdrawal. Med Toxicol 2:367.

    CAS  Google Scholar 

  44. Gossop M (1988) Clonidine and the treatment of the opioid withdrawal syndrome. Drug Alcohol Depend 21:253.

    Article  PubMed  CAS  Google Scholar 

  45. Sweet AY (1982) Narcotic withdrawal syndrome in the newborn. Pediatr Rev 3:285.

    Article  Google Scholar 

  46. Johnstone RE, Lief PL, Kulp RA et al (1975) Combination of delta-9-tetrahydrocannabinol with oxymorphone and pentobarbital. Anesthesiology 42:674.

    Article  PubMed  CAS  Google Scholar 

  47. Stoelting RK, Martz RC, Gartner J et al (1973) Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs. Anesthesiology 38:521.

    Article  PubMed  CAS  Google Scholar 

  48. Parker H, Measham F, Aldridge J (1995) Drug futures. Changing patterns of drug use amongst English youth. Institute for the Study of Drug Dependence, London.

    Google Scholar 

  49. McMiller P, Plant M (1996) Drinking, smoking, and illicit drug use among 15 and 16 year olds in the United Kingdom. British Medical Journal 313:394–397.

    Article  Google Scholar 

  50. Rudat K, Speed M, Ryan H (1992) Today’s young adults: 16’19-year-olds look at alcohol, smoking, drugs and sexual behaviour. Health Education Authority, London

    Google Scholar 

  51. Rudnick G, Wall SC (1992) The molecular mechanism of “ecstasy” [3,4-methylene-dioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA induced serotonin release. Proc Nat Acad Sci 89:1817–1821.

    Article  PubMed  CAS  Google Scholar 

  52. Fuller RW, Hines CW, Mills J (1965) Lowering of brain Serotonin level by Chloramphetamines. Biochem Pharmacol 14:483–488.

    Article  PubMed  CAS  Google Scholar 

  53. Pletscher A, Burkard WP, Brunderer H, Grey KF (1963) Decrease of cerebral 5-hydrox-ytryptamine and 5-hydroxyindolacetic acid by an arylalkylamine. Life Sciences 2:828–833.

    Article  CAS  Google Scholar 

  54. Johnson MP, Hoffman AJ, Nichols DE (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H]dopamine release from the superfused rat brain slices. Eur J Pharmacol 132:269–276.

    Article  PubMed  CAS  Google Scholar 

  55. Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW (1982) Effects of certain hallucinogenic amphetamine analogues on the release of (3H) Serotonin from rat brain synaptosomes. J Med Chem 25:535–538.

    Article  PubMed  Google Scholar 

  56. Schmidt CJ, Levin JA, Lovenberg W (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36:747–755.

    Article  PubMed  CAS  Google Scholar 

  57. Clineschmidt BV, Totaro JA, McGuffin JC, Pflueger AB (1976) Fenfluramine: long-term reduction in brain Serotonin (5-hydroxytryptamine). Eur J Pharmacol 35:211–214.

    Article  PubMed  CAS  Google Scholar 

  58. Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C (1985) Hallucinogenic amphetamine selectively destroys brain serotonin terminals. Science 229:986–988.

    Article  PubMed  CAS  Google Scholar 

  59. McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4 methylenedioxymethamphetamine (MDMA, “ecstasy”). J Neurochem 54:14–22.

    Article  PubMed  CAS  Google Scholar 

  60. Dowling GP, McDonagh ET III, Bost RO (1987) Eve and Ecstasy. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257:1615–1617.

    Article  PubMed  CAS  Google Scholar 

  61. Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylene-dioxymethamphetamine (Ecstasy). Lancet 340:384–387.

    Article  PubMed  CAS  Google Scholar 

  62. Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL (1992) Hyperpyrexia and rhabdomyolysis after MDMA (ecstasy) abuse. Lancet 339:677–678.

    Article  PubMed  CAS  Google Scholar 

  63. Nimmo SM, Kennedy BW, Tullett WM, Blyth AS, Dougall JR (1993) Drug-induced hyperthermia. Anaesthesia 48:892–895.

    Article  PubMed  CAS  Google Scholar 

  64. Singarajah C, Lavies NG (1992) An overdose of ecstasy. A role for dantrolene. Anaesthesia 47:686–687.

    Article  PubMed  CAS  Google Scholar 

  65. Logan AS, Stickle B, O’Keefe N, Hewitson H (1993) Survival following ecstasy ingestion with a peak temperature of 42 degrees C. Anaesthesia 48:1017–1018.

    Article  PubMed  CAS  Google Scholar 

  66. Webb C, Williams V (1993) Ecstasy intoxication: appreciation of complications and the role of dantrolene. Anaesthesia 48:542–543.

    Article  PubMed  CAS  Google Scholar 

  67. Tehan B, Hardern R, Bodenham A (1993) Hyperthermia associated with 3,4-methyl-enedioxyethamphetamine (Eve). Anaesthesia 48:507–510.

    Article  PubMed  CAS  Google Scholar 

  68. Rhodes PJ, Rhodes RS (1984) Elimination kinetics and symptomatology of diazepam withdrawal in abusers. Clin Toxicol 22:371.

    Article  CAS  Google Scholar 

  69. Marchant B, Wray R, Leach A, Nama M (1989) Flumazenil causing convulsions and ventricular tachycardia. Br Med J 299:860.

    Article  CAS  Google Scholar 

  70. Shulgin AT (1980) LSD. J Psychedelic Drugs 12:173.

    Article  PubMed  CAS  Google Scholar 

  71. Khun DM, White FJ, Appel JB (1978) The discriminative stimulus properties of LSD: mechanisms of action. Neuropharmacology 17:257.

    Article  Google Scholar 

  72. McCarron MM, Schulze BW, Thompson GA (1981) Acute phencyclidine intoxication: clinical patterns, complications and treatment. Ann Emerg Med 10:290.

    Article  PubMed  CAS  Google Scholar 

  73. Barton CH, Sterling ML, Vaziri ND (1981) Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. Ann Emerg Med 10:243

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Italia

About this chapter

Cite this chapter

Parr, M.J.A., Hadfield, R.J.H. (1999). Anaesthetic implications of drug abuse in trauma patients. In: Berlot, G., Delooz, H., Gullo, A. (eds) Trauma Operative Procedures. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-2151-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2151-8_15

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0045-2

  • Online ISBN: 978-88-470-2151-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics